Abstract: Optimal and safe control of drug delivery systems with continuous infusion protocol is of key importance to avoid over-or under-dosing of the patient. By implementing close-loops one is able to optimize the amount of drug given to the patient. In this paper a robust control methodology is presented. Emerging tools from fractional calculus have been considered and a fractional order PI controller for drug dosing during hypnosis has been designed. In this paper a robust fractional order control of hypnosis is proposed. The controller has been evaluated on an artificial data set of 24 patients and the results indicate that such a control strategy is robust to uncertainty stemming from the inter-and intra-patient variability.
INTRODUCTION
Automatic drug delivery during anesthesia has been investigated for more than 50 years (Mayo et al., 1950) . However, despite the recent research and clinical trial no real clinical breakthrough has been achieved. Closedloop control of anesthesia paradigm has been the focus of several research groups. Pioneering work of Schwilden el al. (Schwilden et al., 1989) used the median frequency of the electroencephalogram (EEG) as an indication of depth of hypnosis. In the 1990s Mahfouf and Linkens (Mahfouf and Linkens, 1998) proposed a set of model based predictive control methodologies for neuromuscular blockade control. Then, in the late 1990s the development of BIS monitor has reinforced the interest of researchers in closed-loop control of hypnosis (Absalom et al., 2002; Liu et al., 2006; Ionescu et al., 2008) . Many of the studies were performed in small clinical trials and in a well controlled environment, except Liu et al. (Liu et al., 2006) who reported a system successfully tested in a multi-center study and under routine clinical procedures.
Nowadays, in clinical practice the anesthesiologist manually controls the amount of anesthetic drug given to the patient. The commercially available delivery system is the target controlled infusion (TCI) -open loop and no feedback information from patient used. TCI systems use population-based pharmacokinetic (PK) and pharmacodynamic (PD) models to calculate an adequate infusion profile to achieve the drug concentration defined by the anesthesiologist, i.e. patient inter-variability is not taken into account.
To tackle this challenging issue, closed loop control is a good candidate having the potential to reduce the effect of inter-patient variability and improve control of the general anesthetic state (Bibian et al., 2005) . To prove this, feasibility studies have been performed in several clinical trials in adults (Liu et al., 2006) . Again, these studies had a limited impact on clinical practice due to due to concerns about the safety of these systems and the reliability of the sensors. Even more, strong proofs that an improvement in patient outcome is achieved are required in order to convince the medical staff of the benefits of closed loop control system for anesthesia. The large interpatient variability in individual responses to drug infusion is an important cause for concern in the safety of closedloop systems.
Fully automated drug delivery systems for anesthesia will be an important step forward in clinical practice. It contributes to patient safety and reduces the workload of the anesthesiologist while providing him more flexibility to focus on critical issues. Moreover, a cost reduction and a faster return of the patient to daily duties will be achieved. There is significant research in the area of individualized patient models and closed loop control strategies for anesthesia (Ionescu et al., 2008; Padula et al., 2016; Ionescu et al., 2014; Copot et al.) .
In this paper a robust control methodology, i.e. fractional order control, for hypnosis is presented. Tools from fractional calculus will be employed towards an individualized closed-loop control. In the last decades, the popularity of the fractional order controllers has increased considerably, with numerous applications in various fields, such as chem-
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In this paper a robust control methodology, i.e. fractional order control, for hypnosis is presented. Tools from fractional calculus will be employed towards an individualized closed-loop control. In the last decades, the popularity of the fractional order controllers has increased considerably, with numerous applications in various fields, such as chem- ical process control, magnetic levitation, etc (Muresan et al., 2015 (Muresan et al., , 2016b Compared to the integer order controllers, the fractional order ones offer increased flexibility and can honor more closed loop performance constraints simultaneously (Monje et al., 2010) . For this reason, in this paper, a fractional order PI controller is employed to verify if added value exist.
The paper is structured as follows: In Section 2 the pharmacokinetic-pharmacodynamic models used in modeling of anesthesia paradigm are presented. In Section 3 the current state of the art of control of anesthesia is given. In Section 4 the proposed control strategy followed by discussion of the obtained results are presented. The main outcome of this work is summarized in Section 5.
PATIENT MODEL
In automatic regulation of anesthesia, it is common practice to consider Propofol as input and Bispectral Index (BIS) as output variables. BIS is a signal derived from the electro-encephalogram (EEG) and is used in clinical practice to asses the level of consciousness during anesthesia. BIS is defined between 0 (fully sedated) and 100 (fully awake). In general in clinical practice the desired value for BIS is between 40-60 range. The target value during surgery is 50, therefore a range between 40-60 will ensure that we have an adequate level of sedation.
Pharmacokinetic-pharmacodynamic (PK-PD) models are used widely used in anesthesia since they represent the basis of TCI systems. TCI systems are open loop devices, i.e. drug infusion rate is adjusted manually by the anesthesiologist in order to achieve a target plasma concentration, hence, no feedback is available. Despite these disadvantages TCI has become very popular in clinical settings (except North America) due to its ease of use. For Propofol infusion several PK-PD models have been proposed and studies have been performed in order to see the influence of patient biometric parameters on the model parameters (Schnider et al., 1999) .
During general anesthesia the patient receives a hypnotic drug (eg. Propofol) to ensure loss of consciousness and absence of post-operative recall of events occurred during surgery. Additionally, the patient receives a dose of opioid drug (eg Remifentanil) to ensure the absence of pain. Some reasons why Remifentanil is increasingly used in combination with Propofol in todays clinical practice are listed below: i) recently released sophisticated drug delivery systems such as target-controlled infusion allow for precise titration and safe administration in patients with very narrow therapeutic margin; ii) some new clinical applications are currently growing, such as Remifentanil's use as the sole agent for sedation during painful procedures in patients breathing spontaneously, or as the analgesic component in intensive care sedation; iii) simultaneously, Remifentanil has permitted important scientific research, leading to better understanding of postoperative hyperalgesia and acute tolerance to the analgesic action of opioids.
The overall effect of the drug infused in the human body can be then modelled by considering the linear dynamics of its pharmacokinetics and pharmacodynamics in series with a static nonlinear function (Ionescu et al., 2008) .
Most commonly used PK-PD model is the three compartments model schematically depicted in Figure 1 .
In this Figure k 12 , k 21 , k 13 , k 31 , k 1e represent the intercompartmental rate constants, k 10 represents the clearance rate from central compartment. Concentrations in each compartment are denoted by
, C e -effect site compartment, with V 1 , V 2 and V 3 the corresponding compartment volume.
Then, the relation between plasma drug concentration Ce and clinical effect can be mathematically expressed by the means of a nonlinear sigmoid function, known also as Hill function, which models the bispectral index scale (BIS), a dimensionless parameter normalized between 0 and 100, indicating isoline EEG and fully awake patient respectively:
where E 0 is the baseline value representing the initial infusion-free state of the patient, E max is the maximum reachable effect achieved by the infusion, denotes the slope of the curve (i.e., the receptiveness of the patient to the drug) and Ce50 is the necessary concentration of the drug to reach the half maximal effect. It is worth stressing that the Hill function is highly non-linear. In fact, at the beginning of the infusion, the curve presents a plateau, where the presence of little quantities of the drug in the effect compartment does not affect the clinical effect until the drug concentration reaches a certain value. The final saturation expresses the impossibility to overcome the maximum achievable value E max regardless of the amount of hypnotic infused.
To conclude, even if PK-PD model became more and more complex, Hill model remains the fundamental analytical expression for these models (Csajka and Verotta, 2006) . The reasons why this model is used in PK-PD modeling are: (1) can predict the maximum drug effect, which is a key aspect of biological phenomena and (2) the flexibility of the model in fitting data, this is due to the shape parameter γ (known also as the coefficient of sigmoidicity).
CONTROL IN ANESTHESIA
Monitoring and controlling the depth of anesthesia for surgical patients poses interesting challenges to the control engineer (Haddad et al., 2011; Ionescu et al., 2016; Copot and Ionescu, 2014) as it is a multi-variable interaction process that has long captured the attention of engineers and clinicians. From the three main areas of general anesthesia 
